Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis ; volume:21 ; number:1 ; day:23 ; month:9 ; year:2023 ; pages:1-9 ; date:12.2023
Pediatric rheumatology ; 21, Heft 1 (23.9.2023), 1-9, 12.2023
- Urheber
-
Pedersen, Mia Lindegaard
Neve-Græsbøll, Amalie
Herlin, Troels
Glerup, Mia
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12969-023-00897-6
- URN
-
urn:nbn:de:101:1-2024020512012695175705
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pedersen, Mia Lindegaard
- Neve-Græsbøll, Amalie
- Herlin, Troels
- Glerup, Mia
- SpringerLink (Online service)
Ähnliche Objekte (12)
Glucose metabolism in systemic juvenile idiopathic arthritis
Biologic agents in juvenile spondyloarthropathies
Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era
The efficacy and safety profile of biologic therapy with etanercept in juvenile idiopathic arthritis
Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications
Switching to an alternative biological agent in juvenile idiopathic arthritis (II)
Switching to an alternative biological agent in juvenile idiopathic arthritis (I)
Novel IL10 gene family associations with systemic juvenile idiopathic arthritis
Extreme thrombocytosis in systemic juvenile idiopathic arthritis. A case report
Factors associated with choice of first biologic among children with juvenile idiopathic arthritis: a combined analysis from two UK paediatric biologic registers
Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome
The role of extracellular histones in systemic-onset juvenile idiopathic arthritis
Glucose metabolism in systemic juvenile idiopathic arthritis
Biologic agents in juvenile spondyloarthropathies
Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era
The efficacy and safety profile of biologic therapy with etanercept in juvenile idiopathic arthritis
Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications
Switching to an alternative biological agent in juvenile idiopathic arthritis (II)
Switching to an alternative biological agent in juvenile idiopathic arthritis (I)
Novel IL10 gene family associations with systemic juvenile idiopathic arthritis
Extreme thrombocytosis in systemic juvenile idiopathic arthritis. A case report
Factors associated with choice of first biologic among children with juvenile idiopathic arthritis: a combined analysis from two UK paediatric biologic registers
Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome
The role of extracellular histones in systemic-onset juvenile idiopathic arthritis
Glucose metabolism in systemic juvenile idiopathic arthritis
Biologic agents in juvenile spondyloarthropathies
Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era
The efficacy and safety profile of biologic therapy with etanercept in juvenile idiopathic arthritis
Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications
Switching to an alternative biological agent in juvenile idiopathic arthritis (II)
Switching to an alternative biological agent in juvenile idiopathic arthritis (I)
Novel IL10 gene family associations with systemic juvenile idiopathic arthritis
Extreme thrombocytosis in systemic juvenile idiopathic arthritis. A case report
Factors associated with choice of first biologic among children with juvenile idiopathic arthritis: a combined analysis from two UK paediatric biologic registers
Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome